Fri.Jan 03, 2025

article thumbnail

They may be ‘miracle’ drugs, but obesity meds call for a team approach

STAT

Life was getting better for Carlos Campos, 72, a retired machinist who lives with his wife and daughter in Tukwila, Wash. Diagnosed about 20 years ago with type 2 diabetes, he was delighted to see his blood sugar levels improve dramatically about a year ago, when he started taking Ozempic.  Every week, in hour-long appointments, he shared his improved numbers via his continuous glucose monitor’s app with Maureen Chomko, a diabetes educator who works with his primary care physician at

Diabetes 255
article thumbnail

How pharma was instrumental in President Jimmy Carter’s global health efforts

PharmaVoice

Pharma companies stepped up to support The Carter Center and provide access to life-saving treatments.

162
162
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA approves Sequana Medical’s Alfapump for ascites treatment

Pharma Times

FDA gives green light to innovative device for liver conditions

107
107
article thumbnail

FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024

PharmaVoice

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end of recent annual tallies.

130
130
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

CARsgen gets a win for CAR-T in solid tumours

pharmaphorum

CARsgen Therapeutics' claudin 18.2-targeting autologous CAR-T therapy satri-cel has shown efficacy in gastric cancer, setting up a filing in China.

105
105
article thumbnail

NHS Confederation welcomes social care commission announcement

Pharma Times

Government announces independent commission on social care

103
103

More Trending

article thumbnail

CDSCO approves Wockhardt’s new generation oral antibiotic Miqnaf (Nafithromycin)

Express Pharma

The Indian drug regulator, Central Drugs Standard Control Organization (CDSCO) has approved Miqnaf (nafithromycin) as a new treatment for community-acquired bacterial pneumonia (CABP) in Adults. Miqnaf is an ultra-short course, once-a-day, 3-day treatment for CABP including those caused by multi-drug resistant (MDR) pathogens. The approval follows a favourable recommendation for the manufacture and marketing of Nafithromycin from the Subject Expert Committee (SEC) of CDSCO.

article thumbnail

Pharmacy negotiator rails against 'inappropriate' £34m reimbursement reduction

The Pharmacist

The sector will see a reduction in reimbursement of approximately 34m per quarter based on analysis of the Category M price list for January 2025, Community Pharmacy England (CPE) has warned. While a reduction would normally be expected following over-delivery of margin in the previous quarter, CPE argued that enacting it now was 'inappropriate' given […] The post Pharmacy negotiator rails against 'inappropriate' 34m reimbursement reduction appeared first on The Pharmacist.

article thumbnail

Sustaining excellence: The evolving role of quality in pharma

Express Pharma

Quality leaders will need to foster a culture of continuous learning Quality management in the pharmaceutical industry is critical to ensuring the safety, efficacy, and consistency of drugs. However, there are several challenges that pharma companies face in maintaining high-quality standards. Dr Ranjit Barshikar, CEO-QBD International, United Nations Advisor Regulatory compliance and evolving standards: Regulations imposed by authorities such as the FDA, EMA, and other national regulatory bodie

article thumbnail

Regeneron builds in eye disease tech with Oxular takeover

pharmaphorum

Regeneron has bought Oxular, a UK specialist in retinal diseases, in a move that bolsters its already strong position in ophthalmology therapies.

80
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Innovation, partnerships and best practices: Priorities for biopharma in 2025

Express Pharma

Innovation must remain at the core of our efforts Kiran Mazumdar-Shaw, Chairperson, Biocon and Biocon Biologics Indias biopharma sector, currently valued at over $54 billion, is on a promising trajectory, and projected to reach nearly $63 billion by 2025. To emerge as global leaders, Indian biopharma companies must adopt a multifaceted strategy focused on innovation, scalability, and sustainability.

article thumbnail

Patient organisations 'too influenced by corporate funders'

pharmaphorum

Researchers have called for action to safeguard the independence of patient advocacy organisations as they increasingly rely on corporate funding.

75
article thumbnail

Government ‘working towards’ introducing new hub and spoke legislation in 2025

The Pharmacist

The government is working towards introducing legislation to enable hub and spoke dispensing between different legal entities in 2025, pharmacy minister Stephen Kinnock has confirmed. His comments came in response to a written parliamentary question from shadow minister for business and trade Harriett Baldwin. Ms Baldwin asked whether the government plans to bring forward hub […] The post Government working towards introducing new hub and spoke legislation in 2025 appeared first on The Pha

73
article thumbnail

HPLC method demonstrates value for quality control analysis of cardiovascular drug

European Pharmaceutical Review

Researchers have developed a high performance liquid chromatography (HPLC) method that enables accurate determination and precise impurity analysis of the adrenergic -receptor blocker Carvedilol. Carvedilol is commonly used drug to treat cardiovascular diseases , Yuan et al. explained. While there are a variety of methods that can detect and quantify carvedilol, these methods often have limitations in terms of sensitivity, selectivity, or the ability to simultaneously quantify carvedilol and its

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

IIT Guwahati and Bose Institute develop injectable hydrogel for cancer

Pharmaceutical Technology

The Indian Institute of Technology (IIT) Guwahati and the Bose Institute Kolkata research team have developed an advanced injectable hydrogel

64
article thumbnail

NDA in China receives priority review status for lung cancer treatment

Pharmafile

HUTCHMED have announced that the China National Medical Products Administration (NMPA) have granted a priority review for a new drug application (NDA). The NDA will cover the combination of TAGRISSO (osimertinib) and ORPATHYS (savolitinib) in the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer […] The post NDA in China receives priority review status for lung cancer treatment appeared first

64
article thumbnail

Major breakthrough for 'smart cell' design

World Pharma News

Rice University bioengineers have developed a new construction kit for building custom sense-and-respond circuits in human cells. The research, published in the journal Science, represents a major breakthrough in the field of synthetic biology that could revolutionize therapies for complex conditions like autoimmune disease and cancer.

64
article thumbnail

Expanding diagnostic and biomarker options to improve MASH clinical trials

Pharmaceutical Technology

Distinguishing the stages of fibrosis in MASH is a pressing need for diagnoses and clinical trials.

59
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

FDA Releases Draft Guidance on Sampling and Testing of In-Process Materials and Drug Products

PharmaTech

The draft guidance document provides recommendations for complying with 21 CFR 211.110.

article thumbnail

Navigating Access and Reimbursement Through Uncertainty

Pharmaceutical Commerce

A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.

59
article thumbnail

SIGA’s antiviral approved in Japan for orthopoxvirus treatment

Pharmaceutical Technology

SIGA Technologies has gained the Japanese regulatory approval for TEPOXX (tecovirimat) for the treatment of smallpox, mpox and cowpox.

59
article thumbnail

Pharma Pulse 1/3/25: Navigating Fertility Misinformation on Social Media, Nearly 75% of Adolescents Experience Depression/Anxiety & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

59
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

From Davids to Goliaths: the GLP-1R gold rush

Pharmaceutical Technology

There are now more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.

59
article thumbnail

Custom Pet Medication: Tailored Solutions for Your Pet’s Health

Compounding Pharmacy of America

Discover how custom pet medication can address your furry friend's unique health needs. Learn about veterinary compounding and personalized care solutions. The post Custom Pet Medication: Tailored Solutions for Your Pet’s Health appeared first on Compounding Pharmacy of America.

article thumbnail

China’s NMPA prioritises HUTCHMED’s lung cancer therapy review

Pharmaceutical Technology

China NMPA has granted acceptance and priority review for the NDA for HUTCHMEDs ORPATHYS (savolitinib) and TAGRISSO (osimertinib) combination

59
article thumbnail

Everything You Need to Know About Allergy Medicine for Dogs

Compounding Pharmacy of America

Learn about allergy medicine for dogs, including compounded solutions that address specific needs like skin irritations, food allergies, and environmental sensitivities. The post Everything You Need to Know About Allergy Medicine for Dogs appeared first on Compounding Pharmacy of America.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Sanofi, SK Bioscience Launch Phase III Trial Program to Develop PCV21 for Pneumococcal Conjugate Vaccines

PharmExec

PCV21 is the first pneumococcal conjugate vaccine candidate with more than 20 serotypes to enter a Phase III clinical trial in infants and toddlers.

article thumbnail

Seeing is investing: The power of visuals at every stage of development

pharmaphorum

As biotech start-ups evolve, the ability to communicate effectively with key stakeholders those who will fund the next stage of your journey becomes crucial.

article thumbnail

Johnson & Johnson, Kaken Pharmaceutical Strike Licensing Agreement for the STAT6 Program That Targets Autoimmune, Allergic Diseases

PharmExec

Under terms of the deal, Johnson & Johnson will gain an exclusive license to the STAT6 program, with Kaken maintaining commercialization rights in Japan.

52
article thumbnail

Peer Exchange: The Future of RFID and Supply Chain Management (Episode 6)

Pharmaceutical Commerce

In the final part of this roundtable discussion, a panel of subject matter experts discuss what the future holds for this technology, why end-to-end visibility is necessary in healthcare, and the opportunities for greater RFID adoption that lie ahead.

52
article thumbnail

Biotech in the Empire State: Building a World-Class Bioscience Ecosystem in New York

PharmExec

Jennifer Hawks Bland, CEO of NewYorkBIO, shares her journey from litigation to biotech leadership, discusses fostering innovation in New York's thriving bioscience ecosystem, and outlines her vision for the state as a global biotech hub.

52